Jim Simons’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $643K | Sell |
1,506,900
-211,400
| -12% | -$170K | ﹤0.01% | 2504 |
|
|
2026
Q1 | $1.37M | Sell |
1,718,300
-197,600
| -10% | -$229K | ﹤0.01% | 2104 |
|
|
2025
Q4 | $2.49M | Sell |
1,915,900
-939,099
| -33% | -$1.16M | ﹤0.01% | 1730 |
|
|
2025
Q3 | $3.6M | Buy |
2,854,999
+165,660
| +6% | +$263K | ﹤0.01% | 1677 |
|
|
2025
Q2 | $5.57M | Buy |
2,689,339
+414,839
| +18% | +$847K | 0.01% | 1458 |
|
|
2025
Q1 | $5M | Buy |
2,274,500
+1,085,700
| +91% | +$2.11M | 0.01% | 1427 |
|
|
2024
Q4 | $1.82M | Sell |
1,188,800
-819,398
| -41% | -$1.33M | ﹤0.01% | 2120 |
|
|
2024
Q3 | $4M | Buy |
2,008,198
+14,398
| +0.7% | +$34.4K | 0.01% | 1587 |
|
|
2024
Q2 | $6.98M | Sell |
1,993,800
-412,686
| -17% | -$1.27M | 0.01% | 1114 |
|
|
2024
Q1 | $6.67M | Buy |
2,406,486
+523,186
| +28% | +$1.32M | 0.01% | 1233 |
|
|
2023
Q4 | $3.2M | Buy |
1,883,300
+1,592,000
| +547% | +$1.75M | 0.01% | 1641 |
|
|
2023
Q3 | $300K | Sell |
291,300
-767,800
| -72% | -$1.09M | ﹤0.01% | 2933 |
|
|
2023
Q2 | $1.23M | Sell |
1,059,100
-81,736
| -7% | -$146K | ﹤0.01% | 2338 |
|
|
2023
Q1 | $1.72M | Buy |
1,140,836
+814,336
| +249% | +$2.04M | ﹤0.01% | 2122 |
|
|
2022
Q4 | $816K | Buy |
+326,500
| New | +$1.05M | ﹤0.01% | 2656 |
|
|
2021
Q2 | – | Sell |
-162,600
| Closed | -$2.64M | – | 3600 |
|
|
2021
Q1 | $2.64M | Buy |
+162,600
| New | +$2.9M | ﹤0.01% | 2041 |
|
|
2020
Q4 | – | Sell |
-134,800
| Closed | -$2M | – | 3519 |
|
|
2020
Q3 | $2M | Sell |
134,800
-105,000
| -44% | -$1.64M | ﹤0.01% | 2136 |
|
|
2020
Q2 | $3.53M | Sell |
239,800
-812,092
| -77% | -$13.3M | ﹤0.01% | 1845 |
|
|
2020
Q1 | $12.3M | Buy |
1,051,892
+870,892
| +481% | +$16.4M | 0.01% | 1033 |
|
|
2019
Q4 | $4.25M | Buy |
+181,000
| New | +$4M | ﹤0.01% | 1956 |
|
|
2019
Q3 | – | Sell |
-97,400
| Closed | -$1.81M | – | 3538 |
|
|
2019
Q2 | $1.81M | Buy |
+97,400
| New | +$1.95M | ﹤0.01% | 2380 |
|
|
2018
Q4 | – | Sell |
-134,100
| Closed | -$4.24M | – | 3464 |
|
|
2018
Q3 | $4.24M | Sell |
134,100
-258,400
| -66% | -$9.6M | ﹤0.01% | 1910 |
|
|
2018
Q2 | $15.2M | Buy |
+392,500
| New | +$12.5M | 0.02% | 1101 |
|
|
2018
Q1 | – | Sell |
-79,800
| Closed | -$1.44M | – | 3446 |
|
|
2017
Q4 | $1.44M | Buy |
+79,800
| New | +$1.3M | ﹤0.01% | 2508 |
|
|
2015
Q3 | – | Sell |
-48,100
| Closed | -$1.5M | – | 3245 |
|
|
2015
Q2 | $1.5M | Buy |
+48,100
| New | +$905K | ﹤0.01% | 2238 |
|
Other funds holding HRTX
Jim Simons's HRTX Position: Q2 2026 in Review
Jim Simons reduced its Heron Therapeutics (HRTX) stake by 12% in Q2 2026, selling an estimated $170K and leaving 1,506,900 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #2504.
Jim Simons first reported a position in HRTX in Q2 2015 and has held it in 25 quarters since. The position peaked at $15.2M in Q2 2018. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.
- Jim Simons held 1,506,900 shares of Heron Therapeutics worth $643K as of Q2 2026.
- Jim Simons sold 211,400 Heron Therapeutics shares in Q2 2026, an estimated $170K.
- Heron Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2504 holding.
- Jim Simons first reported a position in Heron Therapeutics in Q2 2015 and has held it in 25 quarters since.
- Jim Simons's Heron Therapeutics position peaked at $15.2M in Q2 2018.
- 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.